Divi's Laboratories Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -
6,832.30 +20.85 (0.31%)Updated : 10 Jul 2026
Fiscal Period2026202520242023
Period End DateMar 26Mar 25Mar 24Mar 23
Total Operating Expense 7,656.006,790.006,014.005,741.74
Other Net 296.002.000.004.84
Diluted Weighted Average Shares 26.5426.5526.5526.55
Depreciation/ Amortization 463.00402.00378.00343.18
Operating Income 2,904.002,570.001,831.002,025.77
Net Income 2,568.002,191.001,600.001,823.38
Income Availableto Com Excl Extra Ord 2,568.002,191.001,600.001,823.38
Other Operating Expenses Total 1,584.00---
Net Income Before Taxes 3,388.002,916.002,163.002,368.63
Net Income After Taxes 2,568.002,191.001,600.001,823.38
Income Availableto Com Incl Extra Ord 2,568.002,191.001,600.001,823.38
Costof Revenue Total 4,093.004,348.003,759.003,688.79
Gross Profit 6,467.005,012.004,086.004,078.72
Interest Inc( Exp) Net- Non- Op Total 188.00348.00336.00339.15
Unusual Expense( Income) 74.00---
Diluted Net Income 2,568.002,191.001,600.001,823.38
DPS- Common Stock Primary Issue 30.0030.0030.0030.00
Provisionfor Income Taxes 820.00725.00563.00545.25
period Type ----
Net Income Before Extra Items 2,568.002,191.001,600.001,823.38
Total Revenue 10,560.009,360.007,845.007,767.51
period Length 12.0012.0012.0012.00
Revenue 10,560.009,360.007,845.007,767.51
Selling/ General/ Admin Expenses Total 1,442.001,967.001,811.001,654.40
Diluted Normalized EPS 98.8682.6560.3868.72
Diluted EPS Excluding Extra Ord Items 96.7582.5360.2768.69
Gain( Loss)on Saleof Assets --4.00-4.00-1.13
Research Development -73.0066.0055.37
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,456.05+31.80(2.23%)
1,072.00+21.95(2.09%)
289.70-2.55 (-0.87%)
1,916.05-14.45 (-0.75%)